losartan has been researched along with Ascites in 6 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In cirrhotic patients without ascites, creatinine clearance, 24-h urinary sodium excretion, and fractional excretion of sodium were significantly increased after losartan administration." | 7.71 | One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites. ( Chang, FY; Hou, MC; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY, 2002) |
| "In cirrhotic patients without ascites, creatinine clearance, 24-h urinary sodium excretion, and fractional excretion of sodium were significantly increased after losartan administration." | 3.71 | One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites. ( Chang, FY; Hou, MC; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Cao, J | 1 |
| Melamed, A | 1 |
| Worley, M | 1 |
| Gockley, A | 1 |
| Jones, D | 1 |
| Nia, HT | 1 |
| Zhang, Y | 1 |
| Stylianopoulos, T | 1 |
| Kumar, AS | 1 |
| Mpekris, F | 1 |
| Datta, M | 1 |
| Sun, Y | 1 |
| Wu, L | 1 |
| Gao, X | 1 |
| Yeku, O | 1 |
| Del Carmen, MG | 1 |
| Spriggs, DR | 1 |
| Jain, RK | 1 |
| Xu, L | 1 |
| Therapondos, G | 1 |
| Hol, L | 1 |
| Benjaminov, F | 1 |
| Wong, F | 3 |
| Girgrah, N | 1 |
| Liu, P | 2 |
| Collier, J | 1 |
| Blendis, L | 2 |
| Yang, YY | 1 |
| Lin, HC | 1 |
| Lee, WC | 1 |
| Hou, MC | 1 |
| Lee, FY | 1 |
| Chang, FY | 1 |
| Lee, SD | 1 |
| Fukui, H | 1 |
1 trial available for losartan and Ascites
| Article | Year |
|---|---|
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.
Topics: Aldosterone; Antihypertensive Agents; Ascites; Blood Volume; Homeostasis; Humans; Liver Cirrhosis; L | 2002 |
5 other studies available for losartan and Ascites
| Article | Year |
|---|---|
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma.
Topics: Animals; Antineoplastic Agents; Ascites; Collagen; Disease Models, Animal; Drug Synergism; Extracell | 2019 |
The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Ascites; Dose-Response Relationship, | 2006 |
Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Ascites; Dose-Response Relationship, | 2000 |
One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites.
Topics: Aged; Antihypertensive Agents; Ascites; Creatinine; Female; Fibrosis; Humans; Kidney; Losartan; Male | 2002 |
Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?
Topics: Antihypertensive Agents; Ascites; Fibrosis; Humans; Losartan; Renal Plasma Flow, Effective; Sodium | 2002 |